Quick10K

⚲

MGP Ingredients

Filings

10-K	2020-12-31	Filed 2021-02-25
10-Q	2020-09-30	Filed 2020-10-29
10-Q	2020-06-30	Filed 2020-07-30
10-Q	2020-03-31	Filed 2020-04-30
10-K	2019-12-31	Filed 2020-02-26
10-Q	2019-09-30	Filed 2019-10-31
10-Q	2019-06-30	Filed 2019-07-31
10-Q	2019-03-31	Filed 2019-05-01
10-K	2018-12-31	Filed 2019-02-27
10-Q	2018-09-30	Filed 2018-11-01
10-Q	2018-06-30	Filed 2018-08-02
10-Q	2018-03-31	Filed 2018-05-02
10-K	2017-12-31	Filed 2018-03-01
10-Q	2017-09-30	Filed 2017-11-02
10-Q	2017-06-30	Filed 2017-08-03
10-Q	2017-03-31	Filed 2017-05-04
10-K	2016-12-31	Filed 2017-03-08
10-Q	2016-09-30	Filed 2016-11-02
10-Q	2016-06-30	Filed 2016-08-03
10-Q	2016-03-31	Filed 2016-05-04
10-K	2015-12-31	Filed 2016-03-10
10-Q	2015-09-30	Filed 2015-11-05
10-Q	2015-06-30	Filed 2015-08-06
10-Q	2015-03-31	Filed 2015-05-07
10-K	2014-12-31	Filed 2015-03-12
10-Q	2014-09-30	Filed 2014-11-13
10-Q	2014-06-30	Filed 2014-08-07
10-Q	2014-03-31	Filed 2014-05-08
10-K	2013-12-31	Filed 2014-03-13
10-Q	2013-09-30	Filed 2013-11-13
10-Q	2013-06-30	Filed 2013-08-05
10-Q	2013-03-31	Filed 2013-05-06
10-K	2012-12-31	Filed 2013-03-12
10-Q	2012-09-30	Filed 2012-11-09
10-Q	2012-06-30	Filed 2012-08-09
10-Q	2012-03-31	Filed 2012-05-10
10-K	2011-12-31	Filed 2012-03-13
10-Q	2011-09-30	Filed 2011-11-09
10-K	2011-06-30	Filed 2011-09-02
10-Q	2011-03-31	Filed 2011-05-10
10-Q	2010-12-31	Filed 2011-02-09
10-Q	2010-09-30	Filed 2010-11-09
10-K	2010-06-30	Filed 2010-09-03
10-Q	2010-03-31	Filed 2010-05-11
10-Q	2009-12-31	Filed 2010-02-11

Reports

8-K	2020-10-29
8-K	2020-09-30
8-K	2020-07-30
8-K	2020-06-30
8-K	2020-05-26
8-K	2020-04-30
8-K	2020-04-28
8-K	2020-02-26
8-K	2020-02-12
8-K	2020-02-07
8-K	2020-01-17
8-K	2019-10-31
8-K	2019-09-16
8-K	2019-07-31
8-K	2019-05-23
8-K	2019-05-01
8-K	2019-03-14
8-K	2019-02-27
8-K	2019-01-31
8-K	2018-11-01
8-K	2018-08-02
8-K	2018-05-30
8-K	2018-05-02
8-K	2018-03-01

MGP Ingredients Financials

MGPI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546	323	0	0	0	0	-854
1 800 Flowers Com (FLWS)	944	42%	13.3	6%	665	336	1,266	534	37	75	1,001
10x Genomics (TXG)	4,805	75%	-490.3	-2%	573	151	61	46	-10	-9	4,357
12 Retech (RETC)	0	32%	-0.1	-1,385%	1	20	1	0	-15	-15	1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	34	0%	0.4	-5%	164	108	18	0	-8	-8	-3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	19	23	27	7	-3	-1	3
1895 Bancorp of Wisconsin (BCOW)	46,153		12,508.1	-0%	441	383	0	0	-0	4	46,142
1st Constitution Bancorp (FCCY)	165	0%	4.4	1%	1,343	1,204	0	0	14	33	144
1st Franklin Financial (FFC)	4		-0.6	7%	905	645	0	0	62	80	-46
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200		7.9	1%	6,691	5,858	0	0	70	136	1,073
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	2	0	0	-2	-2	0
21Vianet Group (VNET)	6,005			0%	11,151	5,788	0	0	0	0	3,344
22nd Century (XXII)	302	1%	-14.1	-36%	62	7	26	0	-22	-21	302
1Life Healthcare (ONEM)


Balance Sheet ($MM)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	1	0					0	0	0	3	0	1	0	6	6	4	0	1	0	2	0	2	0	8	7	3	1	2	0	5	0	2	4
Accounts Receivable
Inventory	19	31	34
PP&E	166	77	186	190	189	191	189	190	192	195	196	197	199	198	203	206	220	230	233	238	240	246	250	253	256	267	271	279	282	296	297	300	305
Assets	136	169	170	168	159	163	161	159	155	151	150	155	149	161	167	179	189	194	201	212	220	225	235	242	234	240	245	260	274	278	290	299	307
Accounts Payable	16	23	21	22	15	19	23	19	20	23	19	18	14	16	17	19	21	21	17	21	18	20	17	16	21	30	25	23	23	25	19	21	24
Long-Term Debt	9	9	8	8	7	5	28	31	30	4	23	23	17	10	10	10	29	34	37	41	45	37	44	44	34	25	32	40	45	33	44	43	42
Liabilities	70	85	84	82	72	76	74	71	74	70	65	64	52	56	58	62	80	78	78	82	82	79	80	81	75	72	70	78	83	76	85	86	88
Stockholders' Equity	65	84	86	85	87	87	88	88	81	82	85	91	97	104	108	117	109	116	123	130	138	146	154	160	159	169	175	182	190	201	205	212	219


Income Statement ($MM)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	76	70	86	87	76		89	84	81		85	90	84		85	92	84		77	82	84		91	88	88	88	88	88	95	105	89	91	91
Cost of Revenue	73	70	81	81	70		81	78	80		78	81	77		71	75	72		60	67	69		72	69	69	69	69	69	75	79	72	71	72
Gross Profit	3	0	6	6	6	7	7	5	1	8	7	8	7	6	13	18	12	16	17	16	15	18	19	19	19	20	19	19	20	26	17	20	19
R&D
SG&A	5	6	8	6	6	6	6	5	7	9	5	5	5	5	6	8	5	6	6	6	7	7	8	8	8	9	9	8	8	9	8	9	7
Tax	0	-8	0	-0	0	0		0	0	-1	0	0	-1	3	3	5	1	4	4	4	2	4	3	3	7	-2	1	3	3	4	-1	3	3
Net Income	-6	16	2	-1	0	0	1	0	-6	-0	5	16	6	8	5	8	7	6	7	6	10	8	9	6	14	13	9	8	9	12	10	8	8


Cash Flow ($MM)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating	-14	4	-11	6	2	2	3	-1	2	13	-1	4	6	7	6	3	4	6	-2	2	2	18	-1	12	6	17	1	0	0		-4	7	9
Cash Investing	-0	-12	10	7	16	-1	2	-1	-2	-3	-2	-1	0	5	-5	-3	-12	-10	-3	-3	-5	-6	-6	-3	19	-7	-7	-6	-6		-5	-2	-4
Cash Financing	8	7	0	-7	-12	-2	-5	2	-0	-8	-0	-1	-7	-6	-0	-2	4	5	4	2	2	-10	6	-1	-25	-14	4	7	3		4	-2	-3